Skip Page Header

Home > Consideration of the naphthylpyrovalerone analogues and related compounds.

Advisory Council on the Misuse of Drugs. (2010) Consideration of the naphthylpyrovalerone analogues and related compounds. London: Home Office.

[img]
Preview
PDF (Naphyrone report) - Published Version
133kB

This report is a consideration of naphyrone (also known as NRG-1, Energy1, or O-2482; or naphthylpyrovalerone), a naphthyl analogue of pyrovalerone, which acts as a triple monoamine reuptake inhibitor, producing psychostimulant effects (hereafter referred to as naphyrone). Internationally, it is controlled under Schedule IV of the 1971 UN Conventions.


Item Type
Report
Publication Type
International, Report
Drug Type
CNS stimulants, New psychoactive substance
Intervention Type
Harm reduction
Date
2010
Pages
24 p.
Publisher
Home Office
Corporate Creators
Advisory Council on the Misuse of Drugs
Place of Publication
London
EndNote
Accession Number
HRB (Electronic Only)
Related URLs

Repository Staff Only: item control page